Under the new BBC Charter and Agreement, Ofcom’s role is to hold the BBC’s performance and editorial standards to account, and also to regulate the competitive effects of its services.
The unitary BBC board will be responsible for governing and running the Corporation. The National Audit Office will be responsible for the ensuring the BBC delivers value for money, while the Charter itself – and the licence fee – remain matters for Government.
Ofcom will regulate the content standards of the BBC’s television, radio and on-demand programs. The BBC will handle complaints about its content in the first instance, with Ofcom overseeing that process and handling appeals through a transparent process. Whenever required, Ofcom will step in.
Ofcom also have new duties to consider the effect of the BBC’s services on fair and effective competition in the broadcasting market.
Furthermore, the regulator has new duties to hold the BBC’s performance to account. The Charter sets clear objectives for the BBC to serve audiences, and puts a sharpened focus on distinctive, creative and high quality programs. Ofcom’s draft ‘operating license’, published last week, sets clear requirements on the BBC to uphold the quality of its programs.
Consultations on the draft license, and other aspects of Ofcom’s new framework for regulating the BBC, are open until 17 July.
Full Content: OFCOM
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas